Post-Transition Metal Salts
Strem, An Ascensus Company CAS# 301-10-0. 250g. Tin(II) 2-ethylhexanoate, ~90% in 2-ethylhexanoic acid (~28% Sn). MFCD00002676
CAS# 301-10-0. 250g. Tin(II) 2-ethylhexanoate, ~90% in 2-ethylhexanoic acid (~28% Sn). MFCD00002676. Molecular Weight: 405.11. Molecular Formula: Sn[OOCCH(C2H5)C4H9]2. Color/form: viscous liq. Strem# 93-5037. http://www.strem.com/catalog/v/93-5037/
Strem, An Ascensus Company CAS# 557-20-0. 50g. Diethylzinc, min. 95% (10 wt% in hexanes) (Sure/Seal™ Bottle). MFCD00009021
CAS# 557-20-0. 50g. Diethylzinc, min. 95% (10 wt% in hexanes) (Sure/Seal™ Bottle). MFCD00009021. Molecular Weight: 123.49. Molecular Formula: Zn(C2H5)2. Color/form: colorless liq. Strem# 30-3029. http://www.strem.com/catalog/v/30-3029/
Medchemexpress LLC Pactimibe sulfate | 608510-47-0 | 98.0% | 465.65 | C25H40N2O3.1/2H2O4S | 1 ML
Pactimibe sulfate is a small-molecule dual ACAT1/2 inhibitor used in biochemical and cellular research to investigate cholesterol esterification and related pathways. Supplied as a ready-to-use 10 mM solution in DMSO (1 mL), it has reported low-micromolar activity in enzyme and cell-based assays and is provided at high purity for research applications.
- Ready-to-use 10 mM DMSO solution for biochemical and cellular assays.
- Dual ACAT1/2 inhibitory activity with reported IC50s in the low micromolar range.
- High purity (98.0%) appropriate for research use.
- Suitable for studies of cholesterol esterification and atherosclerosis-related mechanisms.
- Provided in a small-volume solution convenient for screening and dose-response experiments.
Cayman Chemical RoflumIlast N-oxIde 25mg
A PDE4 inhibitor (IC50 = 2 nM) and active metabolite of roflumilast; selective for PDE4 over PDE1-3 and PDE5 (IC50s = >10,000 nM for all); It reduces TNF-α-induced ICAM-1 and eotaxin levels when used in combination with PGE2 in GM06114 human fetal lung fibroblasts (IC50s = 0.9 and 0.5 nM, respectively); reverses cigarette smoke extract-induced reductions in ciliary beat frequency in isolated human bronchial epithelial cells at 2 nM; also increases plasma GLP-1 levels in a glucose challenge in diabetic db/db mice at 10 mg/kg, as well as prevents increases in blood glucose in db/db mice at 3 mg/kg per day
Medchemexpress LLC Lidocaine N-oxide | 2903-45-9 | MFCD22125322 | 99.9% | 250.34 | C14H22N2O2 | 10MG
Lignocaine N-oxide (lidocaine N-oxide) is a drug metabolite used as a reference standard in biochemical and pharmacological research. It is supplied as a powder with characterized solubility and storage recommendations for laboratory use.
- CAS number 2903-45-9 for unambiguous identification.
- Chemical formula C14H22N2O2 and molecular weight 250.34 g/mol.
- Purity 99.9% (reported by supplier) suitable for analytical applications.
- Appearance: powder; solubility: DMSO 100 mg/mL (requires ultrasonic), aqueous formulations achieving ≥5 mg/mL.
- Storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (6 months) or -20°C (1 month).
- Available in mg-scale solid packs and 10 mM solution formats for research use.